Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer
-
Published:2024-03
Issue:3
Volume:50
Page:107968
-
ISSN:0748-7983
-
Container-title:European Journal of Surgical Oncology
-
language:en
-
Short-container-title:European Journal of Surgical Oncology
Author:
van der Zijden Charlène J.ORCID,
van der Sluis Pieter C.,
Mostert BiancaORCID,
Nuyttens Joost J.M.E.,
Spaander Manon C.W.,
Toxopeus Eelke L.A.,
Valkema Roelf,
Beerepoot Laurens V.ORCID,
van Halteren Henk K.,
Lagarde Sjoerd M.,
Wijnhoven Bas P.L.
Reference26 articles.
1. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
2. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial;Ben;J Clin Oncol,2021
3. High pathologic complete remission rate from induction docetaxel, platinum and fluorouracil (DCF) combination chemotherapy for locally advanced esophageal and junctional cancer;Noronha;Med Oncol,2014
4. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma;Satake;Cancer Chemother Pharmacol,2016
5. Induction chemotherapy followed by surgery for advanced oesophageal cancer;Toxopeus;Eur J Surg Oncol,2015